Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 122,536 | 112,214 | 108,631 | 79,858 | 83,395 |
| Cost of Goods | 17,896 | 20,109 | 12,322 | 10,583 | 9,584 |
| Gross Profit | 104,640 | 92,105 | 96,309 | 69,275 | 73,811 |
| Operating Expenses | 124,835 | 101,872 | 96,748 | 86,400 | 74,314 |
| Operating Income | -19,299 | -9,658 | -117 | -16,542 | 81 |
| Other Income | 2,320 | 2,457 | 2,421 | 2,266 | 2,369 |
| Pre-tax Income | -16,979 | -7,201 | 2,304 | -14,276 | 2,450 |
| Income Tax | -8,091 | 5,492 | 6,212 | 3,428 | -22,787 |
| Net Income Continuous | -8,888 | -12,693 | -3,908 | -17,704 | 25,237 |
| Net Income | $-8,888 | $-12,693 | $-3,908 | $-17,704 | $25,237 |
| EPS Basic Total Ops | -0.11 | -0.18 | -0.06 | -0.25 | 0.37 |
| EPS Basic Continuous Ops | -0.12 | -0.18 | -0.06 | -0.25 | 0.36 |
| EPS Diluted Total Ops | -0.11 | -0.18 | -0.06 | -0.25 | 0.37 |
| EPS Diluted Continuous Ops | -0.12 | -0.18 | -0.06 | -0.25 | 0.36 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.18 | -0.06 | N/A | N/A |
| EBITDA(a) | $-18,899 | $-9,259 | $313 | $-16,076 | $621 |